NanoViricides Inc. (NNVC)

[Nanotoday]

We are 2+ years from when NNVC decided to go for the lower hanging fruit. Flucide was already in Tox, and had they stayed the course would have been through at least phase II clinicals by now. To call herpecide the low hanging fruit may be true if they were both started at the same time. But the restart on formulation, manufacturing, optimization...have made herpecide a much slower and more difficult product to get through Tox, than flucide was when they changed course.

This is all moot because they can not produce verifiable duplicate batches. That's why they were forced to stop Flucide. This is why they will not be able to get herpecide through Tox. Making a single test size batch ain't gonna cut it. This is the single biggest obstacle to advancing, and an incredibly convenient excuse when they fold up the tent.

I can see it now: "We did all that we could, we had amazing products that tested through the roof, but our inability to manufacture to scale before our funding ran out was the problem."

Diwan and Seymour get out having only made millions of dollars (10's of millions in the case of Diwan). He played Seymour like a fiddle. Seymour did fine, and he knew exactly where this would end. It was proposed, designed and executed as initially schemed...but went several years longer then either hd ever imagined.